Butterfly Network (BFLY) Net Equity Issued and Repurchased (2025)

Butterfly Network (BFLY) posted Net Equity Issued and Repurchased of -$103000.0 for Q2 2025, down 100.13% sequentially from $81.1 million in Q1 2025.

Butterfly Network (BFLY) Net Equity Issued and Repurchased (2025) Analysis & Trends

Butterfly Network has reported Net Equity Issued and Repurchased for 1 years, with the latest figure at -$103000.0 in Q2 2025.

Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to -$103000.0 in Q2 2025, while the trailing twelve-month figure through Mar 2026 was -$103000.0 (down 100.13% YoY) and the FY2025 annual result came in at $81.0 million, changed N/A from the prior year.
Net Equity Issued and Repurchased fell to -$103000.0 in Q2 2025 per BFLY's latest filing, from $81.1 million in the prior quarter.
Over five years, Net Equity Issued and Repurchased peaked at $81.1 million in Q1 2025 and troughed at -$103000.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Equity Issued and Repurchased (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	-
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	-
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	97.00 Mn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	-
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	-
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	-
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	-
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	-
10	Butterfly Network	2.41 Bn	2.28 Bn	23.29 Mn	-

Download Data